The Exchange has received the disclosure under Regulation 29(1) / 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Kunjal Unadkat
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Promoter Kunjal Piyushbhai Unadkat acquired 18,000 equity shares (0.26%) of Aptus Pharma Limited on 11.05.2026 through what appears to be a promoter group transfer. Before the acquisition, his holding was 5,75,000 shares (8.38%). After the acquisition, his total holding increased to 5,93,000 shares (8.64%) out of 68,60,000 total equity shares of Rs.10 each. The filing indicates the mode as not applicable or unspecified in the standard categories. The acquisition is well below any regulatory threshold triggers and the promoter stake remains modest at under 9%.
Minor incremental promoter stake increase of 0.26%. No immediate material impact on stock price expected as the holding remains low at under 9% and the acquisition is small in percentage terms. However, it signals ongoing promoter accumulation.